Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Levenson, Jeffrey
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)	Recruiting	3	528	US	MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet	Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex	Cataract	12/24	01/25
NCT06164743: Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery	Completed	2	91	US	VVN461 Ophthalmic Solution 1.0%, VVN461 Ophthalmic Solution 0.5%, Vehicle	VivaVision Biotech, Inc	Inflammation	05/24	05/24
NCT04781387: Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection	Active, not recruiting	2	108	Canada, US	CRS3123, Active Comparator	Crestone, Inc, National Institute of Allergy and Infectious Diseases (NIAID)	Clostridioides Difficile Infection	02/24	04/24